They observed that VSL#3 treatment significantly reduced levels of IgM, IgG, and IgA in colon mucus and thedown-regulated the number of T follicular helper (Tfh) cells in mesenteric lymph nodes, thereby possibly alleviating colitis [31]. The gene discussed is CD79A; the disease is colitis.